Clinical Trials Browser

Phase 3 × INDUSTRY × brivanib × Clear all

NCT00908752 2019-12-02

BRISK TA

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT00825955 2019-10-09

BRISK PS

Phase 3 Completed

Gastrointestinal

Liver Neoplasms

NCT01108705 2015-10-12

BRISK-APS

Phase 3 Terminated

Gastrointestinal

Carcinoma, Hepatocellular